Product Overview
CJC-1295 no DAC + Ipamorelin 10 mg is a synergistic growth hormone secretagogue peptide blend designed to stimulate natural GH release in a controlled, pulsatile manner. This combination pairs a short-acting GHRH analog (CJC-1295 no DAC) with a GHRP (Ipamorelin) to maximize physiological GH pulses.
Manufactured by Dragon Pharma, this blend is widely used in research and performance settings for recovery, fat loss, and sleep optimization.
Drug Class
This product belongs to the class of growth hormone secretagogues, combining:
- GHRH analog: CJC-1295 (no DAC)
- Ghrelin receptor agonist (GHRP): Ipamorelin
Indications
Primary Uses (Research Context)
- Growth hormone optimization
- Recovery and tissue repair
- Fat metabolism enhancement
Secondary Uses
- Improved sleep quality
- Anti-aging protocols
- Body composition improvement
Mechanism of Action
The blend works through dual-pathway stimulation of GH release:
- CJC-1295 (no DAC): Stimulates pituitary GH release via GHRH receptors
- Ipamorelin: Activates ghrelin receptors to trigger GH pulses
- Synergistic effect enhances amplitude and frequency of GH secretion
- Maintains physiological GH rhythm without constant elevation
Dosage & Administration
- Typical research dosing: 100–300 mcg per injection
- Frequency: 1–3 times daily
- Administered via subcutaneous injection
- Common timing: before sleep and/or post-training
Note: Not approved for general therapeutic use; dosing varies by protocol.
Pharmacokinetics
- CJC-1295 no DAC: Short half-life (~30 minutes)
- Ipamorelin: Short half-life (~2 hours)
- Produces pulsatile GH release rather than continuous elevation
Effects & Benefits
- Enhanced recovery and tissue repair
- Improved sleep quality
- Increased fat metabolism
- Lean muscle support
Synergy & Stacking
This blend is inherently synergistic but can be combined with other compounds for advanced protocols:
- CJC-1295 DAC: For sustained GH elevation (advanced protocols)
- HGH: Enhances overall GH levels
- BPC-157 / TB-500: Accelerates tissue repair
- Fat loss agents (e.g., AOD-9604): Enhances lipolysis
Stacking should be tailored to specific recovery or performance goals.
HRT/TRT Relevance
This peptide blend is frequently used alongside TRT protocols to improve recovery, sleep, and body composition.
Use in Females
This blend is non-androgenic and generally suitable for females in research settings.
Pre-Use Assessment
- IGF-1 baseline levels
- Sleep and recovery evaluation
- Metabolic panel
Effectiveness
CJC-1295 no DAC combined with Ipamorelin provides a natural and controlled increase in GH secretion, closely mimicking physiological patterns.
Risk Management
Common Side Effects
- Mild water retention
- Injection site irritation
- Headaches
Less Common Effects
Serious Risks
- Potential insulin sensitivity changes (long-term use)
- Excess GH stimulation if overdosed
Mitigation Strategies
- Use appropriate dosing
- Monitor IGF-1 levels
- Avoid excessive frequency
What to Avoid While Using This Blend
- Overdosing or excessive frequency
- Poor sleep habits (reduces effectiveness)
- Combining with unverified compounds
Drug Interactions
- Other GH-related compounds
- Glucose-lowering medications
Conclusion
CJC-1295 no DAC + Ipamorelin 10 mg is a highly effective peptide blend for natural GH optimization, offering improved recovery, fat loss, and sleep through physiological hormone stimulation.
What is CJC-1295 no DAC Ipamorelin used for?
It is used to enhance natural growth hormone release, recovery, and fat metabolism.
How long do CJC and Ipamorelin take to kick in?
Hormonal effects begin within hours, while physical results develop over weeks.
What are the side effects of CJC-1295 and Ipamorelin?
Generally mild, including water retention and injection site irritation.
